Emergent BioSolutions | EBS - هزینه PE به سود





Pe تغییر دادن تاریخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Akebia Therapeutics 1.63K 1.6K 2025-12
ALKERMES 19.54 4.64 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amarin 91.05 88.3 2023-06
ANI Pharmaceuticals 37.99 60.68 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Emergent BioSolutions 14.4 2.25 2022-09
Exelixis 602.31 586.25 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ironwood Pharmaceuticals 204.24 88.19 2024-12
Lexicon Pharmaceuticals 12.44 4.73 2021-06
Lonza 34.34 2.58 2025-12
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Pacira 52.68 23.44 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Sanofi 11.99 1.58 2025-12
Sarepta Therapeutics 27.27 0 2025-09
United Therapeutics 17.32 1.62 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06
Xoma 52.12 3.09 2022-09